# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 14-051V (Not to be published)

* * * * * * * * * * * * * * * * * * * * * * * * * * * * *

* BRUCE BARRETT, * Filed: March 3, 2015

* Petitioner, * * Decision by Stipulation; Damages; v. * Attorney’s Fees and Costs; * Influenza (“Flu”) Vaccine;

SECRETARY OF HEALTH AND * Tetanus-diphtheria-acellular HUMAN SERVICES, * pertussis (“Tdap”) Vaccine; * Guillain-Barré Syndrome (“GBS”) Respondent. *

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * * *

Howard Stern , Werner, Zaroff, et al, Lynbrook, NY, for Petitioner.

Linda Renzi , U.S. Dep’t of Justice, Wa shington, DC, for Respondent.

DECISION AWARDING DAMAGES AND ATTORNEY’S FEES AND COSTS 1

On January 23, 2014, Bruce Barrett filed a petition seeking compensation under the National Vaccine Injury Compensation Program. 2 Petitioner alleges that as a result of receiving a Tetanus-diphtheria-acellular pertussis (“Tdap”) v accine and a trivalent influenza (“flu”) vaccine on January 14, 2013 he suffered from Guillain-Barré syndrome (“GBS”) and that he experienced the residual effects of this inju ry for more than six months.

Respondent denies that either the Tdap vaccine or flu vaccine caused Petitioner’s GBS, or any other injury, and denies that his current disabilities are sequelae of a vaccine-related injury.

1 Because this decision contains a reason ed explanation for my action in this cas e, it will be posted on the website of the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the inclusion of certain kinds of confidential information. To do so, Vaccine Rule 18(b) provides that each party has fourt een (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secr et or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or simila r files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the decision will be available to the public. Id.

2 The National Vaccine Injury Compensation Program comprise s Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C.A. § 300aa-10 to 34 (2006)) [hereinafter “Vaccine Act” or “the Act”]. Indivi dual sections references hereafte r will be to § 300aa of the Act.2 Nonetheless both parties, while maintaining their above-stated positions, agreed in a stipulation (filed February 9, 2015) that the issues before them can be settled and that a decision should be entered awarding Petitioner compensation.

In a separate stipulation (filed on March 2, 2015), the parties indicated that they had reached an agreement regarding attorney’s fees a nd costs. The stipulation laid out the amount of compensation that should be awarded to Petitioner’s attorney in the form of a check made payable jointly to Petitioner and Petitioner’s counsel. In compliance with General Order #9, it also indicated that no out-of-pocket litigation related costs had b een incurred by Petitioner in proceeding on the petition.

I have reviewed the file, and ba sed upon that review, I conclude that the parties’ stipulations are reasonable. I therefore adopt them as my decision in awarding damages, and attorney’s fees and costs, on the terms set forth therein.

The stipulations award:

 A lump sum of $200,000.00 in the form of a check payable to Petitioner. This amount represents compensation for all da mages that would be available under 42

U.S.C. § 300aa-15(a). Stipulation (ECF No. 18) ¶ 8.

 A lump sum of $15,550.00 in the form of a check payable jointly to Petitioner and Petitioner’s attorney, Howard Stern, Esq. for attorney’s fees and costs available

under 42 U.S.C. § 300aa-15(e). Stipulation of Facts Conc erning Final Attorney’s Fees and Costs (ECF No. 19) ¶¶ 4-6.

I approve a Vaccine Program award in the requested amounts set forth above to be made

to Petitioner. In the absence of a motion for re view filed pursuant to RCFC Appendix B, the clerk

of the court is directed to enter judgment herewith. 3

IT IS SO ORDERED.

/s/ Brian H. Corcoran

Brian H. Corcoran Special Master

3 Pursuant to Vaccine Rule 11(a), the parties may expedite en try of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review.